FDA Boxed Warning for Botulinum Toxin Products

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:595 / 596
页数:2
相关论文
共 50 条
  • [21] FDA Boxed Warning for Montelukast: Impact on Adult Severe Asthmatics?
    Tiew, Pei Yee
    Tan, Karen Li Leng
    Koh, Mariko Siyue
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (12) : 1029 - 1030
  • [23] Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning
    Seymour, Sally M.
    Lim, Robert
    Xia, Changming
    Andraca-Carrera, Eugenio
    Chowdhury, Badrul A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26): : 2461 - 2463
  • [24] Public Perceptions of Breast Implant Complications and the FDA Boxed Warning on Implants
    Hyland, Colby J.
    Gadiraju, Goutam
    Parikh, Neil
    Dey, Tanujit
    Broyles, Justin M.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2022, 10 (11) : E4439
  • [27] Evaluating the Effects of a FDA Boxed Warning on Adverse Event Reporting: Is There a Difference in the Rate of Reporting of Tendon-Related Adverse Events Associated with the Use of Fluoroquinolones after a FDA Boxed Warning?
    Olsen, Axel
    Mease, Mary
    Hall, John R.
    Gemmen, Eric
    Garvert, William
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S136 - S136
  • [28] Clopidogrel hyporesponsiveness and the FDA boxed warning: Detection and management of patients with genetic polymorphisms
    Perry, Elizabeth
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (06) : 529 - 532
  • [29] Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning
    Bratsman, Andrew
    Mathias, Kristen
    Laubscher, Rory
    Grigoryan, Larissa
    Rose, Stacey
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (06) : 701 - 707
  • [30] FDA Expands Warning on Diet Products
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (16): : 1646 - 1646